NMR solution structure of the major G-quadruplex structure formed in the human BCL2 promoter region

College of Pharmacy, The University of Arizona, 1703 E. Mabel Street, Tucson, AZ 85721, USA.
Nucleic Acids Research (Impact Factor: 9.11). 02/2006; 34(18):5133-44. DOI: 10.1093/nar/gkl610
Source: PubMed

ABSTRACT BCL2 protein functions as an inhibitor of cell apoptosis and has been found to be aberrantly expressed in a wide range of
human diseases. A highly GC-rich region upstream of the P1 promoter plays an important role in the transcriptional regulation
of BCL2. Here we report the NMR solution structure of the major intramolecular G-quadruplex formed on the G-rich strand of
this region in K+ solution. This well-defined mixed parallel/antiparallel-stranded G-quadruplex structure contains three G-tetrads of mixed
G-arrangements, which are connected with two lateral loops and one side loop, and four grooves of different widths. The three
loops interact with the core G-tetrads in a specific way that defines and stabilizes the overall G-quadruplex structure. The
loop conformations are in accord with the experimental mutation and footprinting data. The first 3-nt loop adopts a lateral
loop conformation and appears to determine the overall folding of the BCL2 G-quadruplex. The third 1-nt double-chain-reversal
loop defines another example of a stable parallel-stranded structural motif using the G3NG3 sequence. Significantly, the distinct major BCL2 promoter G-quadruplex structure suggests that it can be specifically involved
in gene modulation and can be an attractive target for pathway-specific drug design.

Download full-text


Available from: Danzhou Yang, Jul 06, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A series of cationic porphyrin-anthraquinone hybrids bearing either pyridine, imidazole, or pyrazole rings at the meso-positions, have been investigated for their interaction with DNA G-quadruplexes by employing molecular docking and molecular dynamic simulations. Three types of DNA G-quadruplexes were utilized, which comprise of parallel, antiparallel, and mixed-hybrid topologies. The porphyrin hybrids have a preference to bind with parallel and mixed hybrid structures compared to antiparallel structure. This preference arises from the end stacking of porphyrin moiety following G-stem and loop binding of anthraquinone tail, which is not found in antiparallel due to the presence of diagonal and lateral loops that crowd G-quartet. The binding to antiparallel, instead, occurred with poorer affinity through both the loop and wide groove. All sites of porphyrin binding were confirmed by 6 ns molecular dynamics simulation, as well as by the negative value of total binding free energies that were calculated by using the MMPBSA method. Free energy analysis shows that the favorable contribution came from electrostatic term, which supposedly originated from the interaction of either cationic pyridinium, pyrazole, or imidazole groups and the anionic phosphate backbone, and also from van der Waals energy, which primarily contributed through end stacking interaction.
    Journal of biomolecular Structure & Dynamics 03/2015; DOI:10.1080/07391102.2015.1033015 · 2.98 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: A new G-quadruplex structure located in the B-cell CLL/Iymphoma 2 (Bcl-2) P1 promoter and its physiological function related to Bcl-2 transcription have been studied to find a potential anticancer therapeutic target. Methods: Absorption, polyacrylamide gel electrophoresis, fluorescence, circular dichroism, and nuclear magnetic resonance spectra have been employed to determine G-quadruplex structure and the interaction between G-quadruplex and phenanthrolin-dicarboxylate. Real time polymerase chain reaction and luciferase assay were done to assess the physiological function of the G-quadruplex structure. Results: The UV-melting and polyactylamide gel electrophoresis studies show that the p32 DNA sequence forms an intramolecular G-quadruplex structure. Circular dichroism and nuclear magnetic resonance spectra indicate that the G-quadruplex is a hybrid-type structure with four G-tetrads. Fluorescence spectra show that a phenanthroline derivative has a higher binding affinity for p32 G-quadruplex than duplex. Further circular dichroism and nuclear magnetic resonance studies indicate that the phenanthroline derivative can regulate p32 G-quadruplex conformation. Real time polymerase chain reaction and luciferase assays show that the phenanthroline derivative has down-modulated Bcl-2 transcription activity in a concentration-dependent manner. However, no such effect was observed when p32 G-quadruplex was denatured through base mutation. Conclusion: The newly identified G-quadruplex located in the P1 promoter of Bcl-2 oncogene is intimately related with Bcl-2 transcription activity, which may be a promising anticancer therapeutic target. General significance: The newly identified G-quadruplex in the Bcl-2 P1 promoter may be a novel anticancer therapeutic target.
    Biochimica et Biophysica Acta (BBA) - General Subjects 07/2014; 1840(10). DOI:10.1016/j.bbagen.2014.07.014 · 3.83 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The in silico methods for drug discovery are becoming increasingly powerful and useful. That, in combination with increasing computer processor power, in our case using a novel distributed computing grid, has enabled us to greatly enhance our virtual screening efforts. Herein we review some of these efforts using both receptor and ligand-based virtual screening, with the goal of finding new anti-cancer agents. In particular, nucleic acids are a neglected set of targets, especially the different morphologies of duplex, triplex, and quadruplex DNA, many of which have increasing biological relevance. We also review examples of molecular modeling to understand receptors and using virtual screening against G-protein coupled receptor membrane proteins.
    Experimental and Molecular Pathology 07/2009; 86(3):141-50. DOI:10.1016/j.yexmp.2009.01.011 · 2.88 Impact Factor